Parkinson Disease, Secondary
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:neurological_disorder
|
| gptkbp:affects |
central nervous system
|
| gptkbp:alsoKnownAs |
secondary parkinsonism
|
| gptkbp:causedBy |
medications
toxins other neurological diseases |
| gptkbp:characterizedBy |
parkinsonian symptoms
|
| gptkbp:diagnosedBy |
clinical evaluation
|
| gptkbp:distinctiveFeature |
Parkinson's disease (idiopathic)
|
| gptkbp:firstDescribed |
20th century
|
| gptkbp:ICD-10_code |
gptkb:G21
|
| gptkbp:mayBeIrreversible |
true
|
| gptkbp:mayBeReversible |
true
|
| gptkbp:symptom |
bradykinesia
postural instability rigidity tremor |
| gptkbp:treatment |
symptomatic therapy
removal of causative agent |
| gptkbp:bfsParent |
gptkb:D010141
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Parkinson Disease, Secondary
|